Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on Equity

Intelligent Bio Solutions (INBS) Equity Average (2020 - 2025)

Intelligent Bio Solutions has reported Equity Average over the past 5 years, most recently at $9.6 million for Q2 2024.

  • For Q2 2024, Equity Average rose 99.51% year-over-year to $9.6 million; the TTM value through Jun 2024 reached $9.6 million, up 99.51%, while the annual FY2024 figure was $5.9 million, 16.0% up from the prior year.
  • Equity Average for Q2 2024 was $9.6 million at Intelligent Bio Solutions, up from $7.1 million in the prior quarter.
  • Over five years, Equity Average peaked at $17.3 million in Q1 2021 and troughed at -$5.9 million in Q1 2020.
  • A 5-year average of $6.4 million and a median of $7.7 million in 2022 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: soared 445.03% in 2021 and later crashed 71.6% in 2023.
  • Year by year, Equity Average stood at $7.9 million in 2020, then surged by 49.65% to $11.8 million in 2021, then crashed by 34.35% to $7.7 million in 2022, then crashed by 71.6% to $2.2 million in 2023, then soared by 336.85% to $9.6 million in 2024.
  • Business Quant data shows Equity Average for INBS at $9.6 million in Q2 2024, $7.1 million in Q1 2024, and $2.2 million in Q4 2023.